1/16
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/13
05:44 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
1/12
07:20 am
srrk
Scholar Rock Highlights 2026 Strategic Priorities [Yahoo! Finance]
Low
Report
Scholar Rock Highlights 2026 Strategic Priorities [Yahoo! Finance]
1/12
07:00 am
srrk
Scholar Rock Highlights 2026 Strategic Priorities
Low
Report
Scholar Rock Highlights 2026 Strategic Priorities
1/9
07:18 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/9
06:10 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:00 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/6
12:49 am
srrk
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]
Medium
Report
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]
1/5
08:35 am
srrk
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
08:00 am
srrk
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
07:06 am
srrk
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/13
10:57 am
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/11
10:04 am
srrk
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
12/4
01:41 pm
srrk
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans [Yahoo! Finance]
12/3
03:42 pm
srrk
Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/20
06:03 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Medium
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
11:04 am
srrk
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $47.00. They now have an "overweight" rating on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $47.00. They now have an "overweight" rating on the stock.
11/18
09:00 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
11/18
08:00 am
srrk
Scholar Rock to Present at Upcoming Investor Conferences
Medium
Report
Scholar Rock to Present at Upcoming Investor Conferences
11/17
10:23 am
srrk
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at Barclays PLC from $44.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at Barclays PLC from $44.00 to $45.00. They now have an "overweight" rating on the stock.
11/16
11:26 am
srrk
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses [Yahoo! Finance]
11/15
07:37 am
srrk
Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress [Yahoo! Finance]
11/14
03:06 pm
srrk
Scholar Rock (NASDAQ:SRRK) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
11/14
02:39 pm
srrk
Scholar Rock (SRRK): Exploring Valuation After Recent Company Updates Catch Investor Attention [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK): Exploring Valuation After Recent Company Updates Catch Investor Attention [Yahoo! Finance]
11/14
02:07 pm
srrk
Scholar Rock Holding Corporation (SRRK) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Scholar Rock Holding Corporation (SRRK) Q3 2025 Earnings Call Transcript [Seeking Alpha]